Search Results - Paul L. Prather

Refine Results
  1. 1
    The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products

    The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products by Lisa K. Brents, Paul L. Prather

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Synthetic Pot: Not Your Grandfather’s Marijuana

    Synthetic Pot: Not Your Grandfather’s Marijuana by Benjamin M. Ford, Sherrica Tai, William E. Fantegrossi, Paul L. Prather

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?

    Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse? by Kathryn A. Seely, Paul L. Prather, Laura P. James, Jeffery H. Moran

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?

    Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity? by William E. Fantegrossi, Jeffery H. Moran, Anna Radomińska‐Pandya, Paul L. Prather

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs

    Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs by Stephen Safe, Paul L. Prather, Lisa K. Brents, Gayathri Chadalapaka, Indira Jutooru

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

    Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors by Maheswari Rajasekaran, Lisa K. Brents, Lirit N. Franks, Jeffery H. Moran, Paul L. Prather

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy

    Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy by Lisa K. Brents, Sarah M. Zimmerman, Amanda Saffell, Paul L. Prather, William E. Fantegrossi

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

    The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset by Jennifer L. Shoemaker, Kathryn A. Seely, Ronald L. Reed, John P. Crow, Paul L. Prather

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

    Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury by In Young Choi, Chung Ju, Angela M. A. Anthony Jalin, Da In Lee, Paul L. Prather, Won-Ki Kim

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection

    In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection by Ramey Marshell, Tonisha Kearney-Ramos, Lisa K. Brents, William S. Hyatt, Shidie Tai, Paul L. Prather, William E. Fantegrossi

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

    Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity by Lisa K. Brents, Emily E. Reichard, Sarah M. Zimmerman, Jeffery H. Moran, William E. Fantegrossi, Paul L. Prather

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density.

    Ability of delta-opioid receptors to interact with multiple G-proteins is independent of receptor density. by Paul L. Prather, Therese M. McGinn, Laurie J. Erickson, Christopher J. Evans, Horace H. Loh, Ping‐Yee Law

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer

    Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer by Xinyi Liu, Indira Jutooru, Ping Lei, Kyounghyun Kim, Syng‐Ook Lee, Lisa K. Brents, Paul L. Prather, Stephen Safe

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Repeated administration of phytocannabinoid Δ9-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner

    Repeated administration of phytocannabinoid Δ9-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces... by Shidie Tai, William S. Hyatt, Congwei Gu, Lirit N. Franks, Tamara Vasiljevik, Lisa K. Brents, Paul L. Prather, William E. Fantegrossi

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors

    A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors by Kathryn A. Seely, Lisa K. Brents, Anna Radomińska‐Pandya, Gregory W. Endres, Gregory S. Keyes, Jeffery H. Moran, Paul L. Prather

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

    AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies by Kathryn A. Seely, Lisa K. Brents, Lirit N. Franks, Maheswari Rajasekaran, Sarah M. Zimmerman, William E. Fantegrossi, Paul L. Prather

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity

    Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial ag... by Lisa K. Brents, Anna Gallus‐Zawada, Anna Radomińska‐Pandya, Tamara Vasiljevik, Thomas E. Prisinzano, William E. Fantegrossi, Jeffery H. Moran, Paul L. Prather

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids

    Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids by Anna Mazur, Cheryl F. Lichti, Paul L. Prather, A. Zielińska, Stacie M. Bratton, Anna Gallus‐Zawada, Moshe Finel, Grover P. Miller, Anna Radomińska‐Pandya, Jeffery H. Moran

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors

    Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors by Lisa K. Brents, Fabricio Medina-Bolívar, Kathryn A. Seely, Vipin A. Nair, Stacie M. Bratton, Luis Ñopo-Olazabal, Ronak Y. Patel, Haining Liu, Robert J. Doerksen, Paul L. Prather, Anna Radomińska‐Pandya

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

    Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands by Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton, Lisa K. Brents, Cindy L. Moran, Gregory W. Endres, Laura P. James, Paul F. Hollenberg, Paul L. Prather, Anna Radomińska‐Pandya, Jeffery H. Moran

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: